By incorporating a 4'-hydroxy tetracosanoyl tail into a C26/C25 matrix, this molecule tests the immunological impact of terminal ring oxygenation. It helps identify specific lipid ligands that drive the formation of granulomas.
Molecular Weight
2259.6
Molecular Formula
C143H268O17
Source
Chemical synthesis
Form
Solid or liquid
Purity
≥90%
Identity
Confirmed by NMR/HPLC/MS.
Applications
Polar-Nonpolar Balancing: Evaluating how a single hydroxyl group modulates the extreme hydrophobicity of a triple-C26/C25 lipid.
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.